RELMADA THERAPEUTICS, INC. 10-Q

ITEM 5. OTHER INFORMATION None . 21 ITEM 6. EXHIBITS Copies of the following documents are included as exhibits to this report pursuant to Item 601 of Regulation S-K Exhibit No. Title of Document Location 31.1 Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Filed herewithin 31.2 Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Filed herewithin 32.1 Certification of the Chief Executive Officer pursuant to U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* Filed herewithin 32.2 Certification of the Principal Financial Officer pursuant to U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* Filed herewithin 101.INS Inline XBRL Instance Document. Filed herewithin 101.SCH Inline XBRL Taxonomy Extension Schema Document. Filed herewithin 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. Filed herewithin 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. Filed herewithin 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. Filed herewithin 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. Filed herewithin 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). Filed herewithin * The Exhibit attached to this Form 10-Q shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to liability under that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. 22 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: May 8, 2024 By: /s/ Sergio Traversa Sergio Traversa Chief Executive Officer (Duly Authorized Officer and Principal Executive Officer) /s/ Maged Shenouda Maged Shenouda Chief Financial Officer (Duly Authorized Officer and Principal Financial and Accounting Officer) 23